A. Ritchie (London, United Kingdom), L. Lahousse (Ghent, Belgium), N. Greening (Leicester (Leicestershire), United Kingdom), C. Rhee (Seoul, Republic of Korea)
Real-world medication use patterns in stable COPD patients from Romania
F. Mihaltan (Bucharest, Romania), P. Postolache (Iasi, Romania), O. Arghir (Constanta, Romania), O. Fira-Mladinescu (Timisoara, Romania), A. Silviu (Bucharest, Romania)
|   |
COPD characteristics and progression of patients with high vs low health status: an analysis of the observational DACCORD study
H. Worth (Fuerth, Germany), C. Criée (Bovenden, Germany), P. Kardos (Frankfurt am Main, Germany), V. Obermoser (Nuremberg, Germany), K. Berschneider (Nuremberg, Germany), R. Buhl (Mainz, Germany), C. Vogelmeier (Marburg, Germany)
| |
The frequent exacerbator in real-life: an analysis of the DACCORD study
C. Vogelmeier (Marburg, Germany), C. Criée (Bovenden, Germany), H. Worth (Fuerth, Germany), V. Obermoser (Nuremberg, Germany), K. Berschneider (Nuremberg, Germany), P. Kardos (Frankfurt am Main, Germany), R. Buhl (Mainz, Germany)
| |
Different methods to classify COPD patients into the ABCD severity groups – Preliminary results of the LQ-DMP project
B. Szentes (Neuherberg, Germany), L. Schwarzkopf (Neuherberg, Germany), F. Kirsch (Neuherberg, Germany), M. Huber (Neuherberg, Germany), A. Schramm (München, Germany), R. Leidl (Neuherberg, Germany)
| |
Health care resource utilization (HCRU) in early and late diagnosed Chronic Obstructive Pulmonary Disease (COPD) patients in UK primary care
K. Kostikas (Ioannina, Greece), E. Leofroth (Basel, Switzerland), R. Fogel (East Hanover, United States of America), A. Clemens (Basel, Switzerland), F. Gutzwiller (Basel, Switzerland), I. Kottakis (Basel, Switzerland), B. Jones (Cardiff, United Kingdom), H. Cao (East Hanover, United States of America)
| |
Clinical consequences of late Chronic Obstructive Pulmonary Disease (COPD) diagnosis compared to early diagnosis in UK primary care
K. Kostikas (Ioannina, Greece), E. Loefroth (Basel, Switzerland), R. Fogel (East Hanover, United States of America), A. Clemens (Basel, Switzerland), F. Gutzwiller (Basel, Switzerland), I. Kottakis (Basel, Switzerland), B. Jones (Cardiff, United Kingdom), H. Cao (East Hanover, United States of America)
| |
Impact of halotherapy on COPD exacerbations
V. Sandu (Iasi, Romania), T. Mihaescu (Iasi, Romania), D. Filipeanu (Iasi, Romania), A. Cernomaz (Iasi, Romania), R. Crisan-Dabija (Iasi, Romania)
| |
Are COPD patients taking triple combination inhalers being overmedicated during acute exacerbations?
A. Moran (Oxford, United Kingdom), S. Poole (Oxford, United Kingdom), M. Harding (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom)
| |
Retrospective study on the use of LABA/LAMA therapy (long acting bronchodilator agent/long acting muscarinic agent) in patients with severe COPD at first diagnosis.
F. Bini (Garbagnate Milanese, Italy), N. Grassi (Garbagnate Milanese, Italy), A. De Lauretis (Garbagnate Milanese, Italy), B. Bodini (Novara, Italy), C. Arosio (Garbagnate Milanese, Italy), A. Vaghi (Garbagnate Milanese, Italy)
| |
An integrated care intervention (ICI) reduces readmissions after a hospitalization for acute exacerbation of COPD
M. Moretti (Massa, Italy), S. Balestracci (Massa, Italy), M. Latorre (Massa, Italy), A. Porcu (Massa, Italy), D. Mignani (Massa, Italy), F. Magnani (Massa, Italy), A. Rocchi (Massa, Italy), L. Villari (Massa, Italy), B. Marsiglia (Massa, Italy)
| |
Data-driven prescription patterns in patients under maintenance treatment for respiratory diseases from the Portuguese prescription database
A. Sá-Sousa (Porto, Portugal), R. Amaral (Porto, Portugal), R. Almeida (Porto, Portugal), A. Freitas (Porto, Portugal), J. A Fonseca (Porto, Portugal)
| |
Patient pathway modelling using Discrete Event Simulation to reduce readmissions in COPD
U. Yakutcan (Hatfield, United Kingdom), E. Demir (Hatfield, United Kingdom), J. Hurst (London, United Kingdom), P. Taylor (Hatfield, United Kingdom)
| |
Use of Principal Component and Cluster Analysis to Describe Phenotypes in COPD.
H. Nekoee Zahraei (Liège, Belgium), F. Guissard (Liège, Belgium), V. Paulus (Liège, Belgium), M. Henket (Liège, Belgium), A. Donneau (Liège, Belgium), R. Louis (Liège, Belgium)
| |
The impact and quality outcomes of a community based COPD annual review service
E. Rickards (Liverpool, United Kingdom), D. Kadar (Liverpool, United Kingdom), S. Sibley (Liverpool, United Kingdom), D. Wat (Liverpool, United Kingdom), E. Gossage (Liverpool, United Kingdom)
| |
Recent trends in inhaled corticosteroid prescriptions and its impact on COPD management: an analysis of the KOLD/KOCOSS cohorts
S. Lee (Seoul, Republic of Korea), J. Lee (Seongnam, Republic of Korea), H. Yoon (Seongnam, Republic of Korea), H. Park (Seoul, Republic of Korea), T. Kim (Guri, Republic of Korea), K. Yoo (Seoul, Republic of Korea), Y. Oh (Seoul, Republic of Korea), K. Jung (Anyang, Republic of Korea), S. Lee (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea)
| |
Risk of bacterial infection in COPD patients with Vitamin D defficiency
R. Jha (Faridabad, India)
| |
Real World Effects of Medications for COPD - a UK Population-Based Non-Interventional Cohort Study With Validation Against Randomised Trial Results
K. Wing (London, United Kingdom), E. Williamson (London, United Kingdom), J. Carpenter (London, United Kingdom), L. Wise (London, United Kingdom), S. Schneeweiss (Boston, United States of America), L. Smeeth (London, United Kingdom), J. Quint (London, United Kingdom), I. Douglas (London, United Kingdom)
| |
Treatment patterns in stable COPD patients – results from a large observational European study (SPACE)
Y. Adir (Haifa, Israel), A. Horner (Linz, Austria), G. De Vries (Sittard, Netherlands), F. Mihaltan (Bucharest, Romania), Y. Chen (Shanghai, China), S. Alecu (Bucharest, Romania), L. Adamek (Luton, United Kingdom)
| |
Clinical control of COPD according to outpatient respiratory clinics: general versus specialized COPD
G. Vargas Centanaro (Madrid, Spain), M. Calle Rubio (Madrid, Spain), E. Forcen Vicente De Vera (Madrid, Spain), G. Rubio De La Garza (Madrid, Spain), A. Palomar Santamaria (Madrid, Spain), F. Pelaez Castro (Madrid, Spain), S. Smaili (Madrid, Spain), A. Albuja (Madrid, Spain), J. Rodriguez Hermosa (Madrid, Spain)
| |
Late Breaking Abstract - Assessment of physical functioning and handling with Tiotropium/Olodaterol (T/O) in patients with COPD requiring long-acting dual bronchodilation in an Italian cohort of patients.
A. Pennisi (Catania, Italy), M. Carone (Pavia, Italy), M. D'Amato (Napoli, Italy), A. Fiore Donati (L'Aquila, Italy), V. Ronsivalle (Catania, Italy), M. Aliani (Pavia, Italy), C. Scognamillo (Milano, Italy), L. Chun (Ridgefield, United States of America), G. Pelaia (Catanzaro, Italy)
| |